Thursday, February 16, 2017 10:06:11 AM
Recent GENE News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 01:00:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2024 01:00:25 PM
- Launching our most comprehensive test and expanding into new global markets • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/09/2024 01:00:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2024 01:00:16 PM
- Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:09 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/28/2023 01:00:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 01:00:13 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 12/20/2023 10:00:51 PM
- GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial • GlobeNewswire Inc. • 10/30/2023 12:00:00 PM
- GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment • GlobeNewswire Inc. • 10/18/2023 12:30:00 PM
- GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network • GlobeNewswire Inc. • 09/27/2023 01:00:00 PM
- Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release • GlobeNewswire Inc. • 09/12/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:30:14 PM
- GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner • GlobeNewswire Inc. • 09/11/2023 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:00:10 PM
- Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV • GlobeNewswire Inc. • 09/01/2023 02:00:00 PM
- Annual Results – Momentum Building on our Commercial Plans • GlobeNewswire Inc. • 08/30/2023 12:45:00 PM
- Genetic Technologies Limited Announces Updated Investor Presentation • GlobeNewswire Inc. • 08/09/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/28/2023 12:00:33 PM
HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • HLYK • Mar 19, 2024 8:00 AM
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • ELAB • Mar 18, 2024 8:51 AM
Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • PEI • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM